MIRAPEXIN 0.52 mg prolonged-release tablets

Company
Boehringer Ingelheim Limited
Active Ingredient
Dosage Form
Prolonged-release tablet
Legal Category
B - prescription, may be renewed

*further information is available on request to the holder of the authorisation or in the SPC

Licence number Strength ATC Code Dosage Form
EU/1/97/051/16 0.52 milligram(s) N04BC05 Prolonged-release tablet
EU/1/97/051/17 0.52 milligram(s) N04BC05 Prolonged-release tablet
EU/1/97/051/18 0.52 milligram(s) N04BC05 Prolonged-release tablet
Licence number
EU/1/97/051/16
Strength
0.52 milligram(s)
ATC Code
N04BC05
Dosage Form
Prolonged-release tablet
Licence number
EU/1/97/051/17
Strength
0.52 milligram(s)
ATC Code
N04BC05
Dosage Form
Prolonged-release tablet
Licence number
EU/1/97/051/18
Strength
0.52 milligram(s)
ATC Code
N04BC05
Dosage Form
Prolonged-release tablet

Boehringer Ingelheim Limited

The Crescent Building, , Northwood, Santry, Dublin 9

Email
medinfo.ukie@boehringer-ingelheim.com